Over the last decade, medicine shortages have been an increasing challenge. Among the policy measures to improve the resilience of the supply chain and thus to mitigate and prevent medicine shortages, reshoring of pharmaceutical production to Europe, including active pharmaceutical ingredients (APIs), has been proposed as one potential solution.
The Lunch Lecture will point out various aspects, such as key facts about the current pharmaceutical production (focusing on APIs) in Europe and information on initiatives where efforts were undertaken to strengthen European production. Furthermore, potential benefits and the associated challenges of local pharmaceutical production and measures to strengthen the pharmaceutical supply chain were analysed and discussed.
Stefan Fischer (Dipl.-Ges.ök) is a health economist and health expert at the Pharmacoeconomics Department at the Austrian National Public Health Institute (Gesundheit Österreich GmbH, GÖG).
He has extensive experience in international and national research of pharmaceutical systems and pharmaceutical policies, such as pricing and reimbursement of medicines. Stefan Fischer has also done deepening research regarding medicine shortages, the pharmaceutical supply chain and local production of medicines.
Welcoming and facilitation
Verena Knoll, MA
Pharmacoeconomics Department,
Austrian National Public Health Institute (GÖG)
*** The event took place in the framework of the European Public Health Week – Public health: Global issues, local actions ***